Loading…

Pharmacologic treatment of fibromyalgia

Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management s...

Full description

Saved in:
Bibliographic Details
Published in:Current psychiatry reports 2006-11, Vol.8 (6), p.464-469
Main Authors: Baker, Kathryn, Barkhuizen, Andre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43
container_end_page 469
container_issue 6
container_start_page 464
container_title Current psychiatry reports
container_volume 8
creator Baker, Kathryn
Barkhuizen, Andre
description Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.
doi_str_mv 10.1007/s11920-006-0052-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2406909495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2406909495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</originalsourceid><addsrcrecordid>eNotkDtPAzEQhC0EEiHwA-hOoqAy7Pp1cYkiXlIkKKC29hw7XJSLg30p8u-501GMZorR7Opj7BbhAQHqx4JoBXAAM0gLbs_YDLXUHI3S52MWkssFikt2VcoWQAAsxIzdf_5Q7sinXdq0vupzoL4L-75KsYptk1N3ot2mpWt2EWlXws2_z9n3y_PX8o2vPl7fl08r7tHonjemVsGilaKJWEMQJmAU1EBjFC1qRRTqNUZlfBBkhse1WZvorSRPtSUl5-xu2j3k9HsMpXfbdMz74aQTCowFq6weWji1fE6l5BDdIbcd5ZNDcCMPN_FwAw838nBW_gFfDlH0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406909495</pqid></control><display><type>article</type><title>Pharmacologic treatment of fibromyalgia</title><source>Springer Nature</source><creator>Baker, Kathryn ; Barkhuizen, Andre</creator><creatorcontrib>Baker, Kathryn ; Barkhuizen, Andre</creatorcontrib><description>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</description><identifier>ISSN: 1523-3812</identifier><identifier>EISSN: 1535-1645</identifier><identifier>DOI: 10.1007/s11920-006-0052-9</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><subject>Fibromyalgia ; Psychiatry</subject><ispartof>Current psychiatry reports, 2006-11, Vol.8 (6), p.464-469</ispartof><rights>Current Science Inc 2006.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Baker, Kathryn</creatorcontrib><creatorcontrib>Barkhuizen, Andre</creatorcontrib><title>Pharmacologic treatment of fibromyalgia</title><title>Current psychiatry reports</title><description>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</description><subject>Fibromyalgia</subject><subject>Psychiatry</subject><issn>1523-3812</issn><issn>1535-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNotkDtPAzEQhC0EEiHwA-hOoqAy7Pp1cYkiXlIkKKC29hw7XJSLg30p8u-501GMZorR7Opj7BbhAQHqx4JoBXAAM0gLbs_YDLXUHI3S52MWkssFikt2VcoWQAAsxIzdf_5Q7sinXdq0vupzoL4L-75KsYptk1N3ot2mpWt2EWlXws2_z9n3y_PX8o2vPl7fl08r7tHonjemVsGilaKJWEMQJmAU1EBjFC1qRRTqNUZlfBBkhse1WZvorSRPtSUl5-xu2j3k9HsMpXfbdMz74aQTCowFq6weWji1fE6l5BDdIbcd5ZNDcCMPN_FwAw838nBW_gFfDlH0</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Baker, Kathryn</creator><creator>Barkhuizen, Andre</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20061101</creationdate><title>Pharmacologic treatment of fibromyalgia</title><author>Baker, Kathryn ; Barkhuizen, Andre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Fibromyalgia</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Kathryn</creatorcontrib><creatorcontrib>Barkhuizen, Andre</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Current psychiatry reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Kathryn</au><au>Barkhuizen, Andre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacologic treatment of fibromyalgia</atitle><jtitle>Current psychiatry reports</jtitle><date>2006-11-01</date><risdate>2006</risdate><volume>8</volume><issue>6</issue><spage>464</spage><epage>469</epage><pages>464-469</pages><issn>1523-3812</issn><eissn>1535-1645</eissn><abstract>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1007/s11920-006-0052-9</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1523-3812
ispartof Current psychiatry reports, 2006-11, Vol.8 (6), p.464-469
issn 1523-3812
1535-1645
language eng
recordid cdi_proquest_journals_2406909495
source Springer Nature
subjects Fibromyalgia
Psychiatry
title Pharmacologic treatment of fibromyalgia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacologic%20treatment%20of%20fibromyalgia&rft.jtitle=Current%20psychiatry%20reports&rft.au=Baker,%20Kathryn&rft.date=2006-11-01&rft.volume=8&rft.issue=6&rft.spage=464&rft.epage=469&rft.pages=464-469&rft.issn=1523-3812&rft.eissn=1535-1645&rft_id=info:doi/10.1007/s11920-006-0052-9&rft_dat=%3Cproquest_cross%3E2406909495%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406909495&rft_id=info:pmid/&rfr_iscdi=true